人工肝支持系统治疗重型肝炎36例临床分析  

Clinical Analysis of Artificial Liver Support System in Treatment of 36 Patients with Severe Hepatitis

作　　者：郭威[1] 陶新学[1] 丁红芳[1] 田德英[1] 

机构地区：[1]华中科技大学同济医学院附属同济医院,430030

出　　处：《中西医结合肝病杂志》2002年第3期131-133,共3页Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases

摘　　要：目的:探讨人工肝血浆置换法治疗重型肝炎的疗效、安全性及影响疗效的因素。方法:36例重型肝炎患者在内科治疗基础上给予血浆置换治疗74例次。结果:36例重型肝炎患者经血浆置换治疗后,临床症状都得到一定程度的改善,肝功能明显好转。总存活率为 63.9％(23/36),总不良反应率为 24.3％(18/74),病人耐受性好。结论:血浆置换对于重型肝炎是一种安全有效的治疗方法,宜早期进行。Objectives: To study the effect, the reliability and the factors influencing the therapeutic results of artificial liver support system (plasma exchange) in the treatment of severe hepatitis. Methods: 36 patients with severe hepatitis was treated 74 times by using the plasma exchange device on the basis of medical treatments. Results:36 patients were relieved in clinical symptom and their liver functions were obviously improved after the treatment of plasma exchange. The general survival rate was 63. 9% (23/36). The general side effect rate was 24. 3% (18/74) and the patient's tolerance was good. Conclusions: Plasma exchange is an effective and safe means for thearpy of severe hepatitis. The therapy should be used in early stage.

关 键 词：人工肝支持系统 治疗 重型肝炎 临床分析 血浆置换法 

分 类 号：R575.1[医药卫生—消化系统]